News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Inflazyme Pharmaceuticals Ltd. (IZP.TO) Announces Closing of Transaction With Biolipox AB


11/20/2007 4:16:34 PM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 19, 2007) - Inflazyme Pharmaceuticals Ltd. (TSX: IZP) announced today that it has completed its previously announced sale of substantially all of its research and development assets to Biolipox AB. The transaction was approved at Inflazyme's AGM and Special Meeting of Shareholders on November 16, 2007. Of the votes cast, 98 per cent were in favor of the transaction.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES